United States Biotechnology & Medical Research

Melinta Therapeutics Inc (MLNTQ)

Track

Track

Ticker: MLNTQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
JOHNSON JOHN Chief Executive Officer Executive Director
Transaction date
Sale
Price
189.31
Quantity 90,517 -38.9%
Value US$2,197,856
Duffy Erin Chief Scientific Officer Officer
Transaction date
Purchase
Price
393.22
Quantity 45,862 +12.5%
Value US$2,285,156
ZACCARDELLI DAVID Non-Executive Director
Transaction date
Purchase
Price
202.69
Quantity 67,632 -11.7%
Value US$897,541
Wechsler Daniel Mark See Remarks Executive Director
Transaction date
Purchase
Price
5.00
Quantity 50,000 +inf%
Value US$250,000
Cammarata Sue Chief Medical Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 4,000 +inf%
Value US$20,000
Estrem Paul Chief Financial Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 10,000 +inf%
Value US$50,000
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 7,878,500 +90.3%
Value US$39,392,500
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 7,878,500 +90.3%
Value US$39,392,500
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 7,500,000 +88.2%
Value US$37,500,000
GILL DAVID N Non-Executive Director
Transaction date
Purchase
Price
6.09
Quantity 5,000 +500.0%
Value US$30,450
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.50
Quantity 2,000,000 +29.7%
Value US$27,000,000
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.50
Quantity 2,000,000 +29.7%
Value US$27,000,000
Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.50
Quantity 1,777,778 +26.4%
Value US$24,000,003
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Sale
Price
3.57
Quantity 99,900 -100.0%
Value US$356,443
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Sale
Price
3.53
Quantity 50,100 -33.4%
Value US$176,673
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Sale
Price
3.40
Quantity 105,460 -41.3%
Value US$358,564
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Sale
Price
3.64
Quantity 437,600 -63.1%
Value US$1,592,864
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Sale
Price
3.20
Quantity 500,000 -41.9%
Value US$1,600,000
GILL DAVID N Non-Executive Director
Transaction date
Purchase
Price
2.94
Quantity 5,000 +inf%
Value US$14,720
Moore David Chief Commercial Officer Officer
Transaction date
Purchase
Price
16.18
Quantity 500 +50.0%
Value US$8,090
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Planned sale
Price
30.06
Quantity 842 -94.4%
Value US$25,314
Oldach David W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,778 -61.8%
Value US$53,340
Oldach David W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.33
Quantity 8,222 -88.2%
Value US$249,373
Oldach David W. Chief Medical Officer Officer
Transaction date
Sale
Price
28.78
Quantity 2,200 -66.7%
Value US$63,316
Oldach David W. Chief Medical Officer Officer
Transaction date
Sale
Price
28.78
Quantity 10,000 -75.2%
Value US$287,800
DOUGHERTY MICHAEL R Non-Executive Director
Transaction date
Purchase
Price
18.45
Quantity 2,000 +inf%
Value US$36,896
Kong Garheng Non-Executive Director
Transaction date
Purchase
Price
17.43
Quantity 2,830 +inf%
Value US$49,335
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Planned sale
Price
35.74
Quantity 50,000 -99.9%
Value US$1,787,000
Fernandes Prabhavathi President and CEO Executive Director
Transaction date
Sale
Price
35.72
Quantity 9,000 -3.5%
Value US$321,489
JOHNSON JOHN Non-Executive Director
Transaction date
Purchase
Price
9.10
Quantity 10,000 +inf%
Value US$90,980
NEFF P SHERRILL Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 265,000 +8.1%
Value US$1,855,000
Quaker BioVentures II LP Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 265,000 +8.1%
Value US$1,855,000
Fernandes Prabhavathi President and CEO Executive Director
Transaction date
Purchase
Price
8.60
Quantity 3,500 +1.7%
Value US$30,100
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,025 +0.2%
Value US$6,150
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 16,667 +3.5%
Value US$100,002
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,025 +0.2%
Value US$6,150
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 16,666 +3.6%
Value US$99,996
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,025 +0.2%
Value US$6,150
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 16,666 +3.3%
Value US$99,996
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,025 +0.1%
Value US$6,150
MORRIS I WISTAR III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 16,667 +2.3%
Value US$100,002
Intersouth Associates VI, LLC Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 732,989 +119.7%
Value US$4,397,934
NEFF P SHERRILL Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,189,805 +57.4%
Value US$7,138,830
Intersouth Associates VI, LLC Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 488,659 +33.0%
Value US$2,931,954
Aisling Capital II LP Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 1,213,663 +58.4%
Value US$7,281,978
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Purchase
Price
6.00
Quantity 1,213,663 +58.4%
Value US$7,281,978
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-02 2019-06-27 S Sale
3.1
JOHNSON JOHN

Chief Executive Officer

Executive Director
90,517 -38.9%
189.31
US$2,197,856 		90,517 -38.9% 189.31 US$2,197,856
2018-05-31 2018-05-29 B Purchase Duffy Erin

Chief Scientific Officer

Officer
45,862 +12.5%
393.22
US$2,285,156 		45,862 +12.5% 393.22 US$2,285,156
2018-05-31 2018-05-29 B Purchase ZACCARDELLI DAVID Non-Executive Director
67,632 -11.7%
202.69
US$897,541 		67,632 -11.7% 202.69 US$897,541
2018-05-31 2018-05-29 B Purchase Wechsler Daniel Mark

See Remarks

Executive Director
50,000 +inf%
5.00
US$250,000 		50,000 +inf% 5.00 US$250,000
2018-05-31 2018-05-29 B Purchase Cammarata Sue

Chief Medical Officer

Officer
4,000 +inf%
5.00
US$20,000 		4,000 +inf% 5.00 US$20,000
2018-05-31 2018-05-29 B Purchase Estrem Paul

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,500,000 +88.2%
5.00
US$37,500,000 		7,500,000 +88.2% 5.00 US$37,500,000
2018-05-30 2018-05-25 B Purchase GILL DAVID N Non-Executive Director
5,000 +500.0%
6.09
US$30,450 		5,000 +500.0% 6.09 US$30,450
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
1,777,778 +26.4%
13.50
US$24,000,003 		1,777,778 +26.4% 13.50 US$24,000,003
2017-03-09 2017-03-08 S Sale GOLDSTEIN DOV A MD Non-Executive Director
99,900 -100.0%
3.57
US$356,443 		99,900 -100.0% 3.57 US$356,443
2017-03-09 2017-03-07 S Sale GOLDSTEIN DOV A MD Non-Executive Director
50,100 -33.4%
3.53
US$176,673 		50,100 -33.4% 3.53 US$176,673
2017-01-18 2017-01-13 S Sale GOLDSTEIN DOV A MD Non-Executive Director
105,460 -41.3%
3.40
US$358,564 		105,460 -41.3% 3.40 US$358,564
2017-01-06 2017-01-06 S Sale GOLDSTEIN DOV A MD Non-Executive Director
437,600 -63.1%
3.64
US$1,592,864 		437,600 -63.1% 3.64 US$1,592,864
2017-01-06 2017-01-05 S Sale GOLDSTEIN DOV A MD Non-Executive Director
500,000 -41.9%
3.20
US$1,600,000 		500,000 -41.9% 3.20 US$1,600,000
2017-01-04 2017-01-03 B Purchase GILL DAVID N Non-Executive Director
5,000 +inf%
2.94
US$14,720 		5,000 +inf% 2.94 US$14,720
2016-03-02 2016-03-01 B Purchase Moore David

Chief Commercial Officer

Officer
500 +50.0%
16.18
US$8,090 		500 +50.0% 16.18 US$8,090
2016-01-06 2016-01-04 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
842 -94.4%
30.06
US$25,314 		842 -94.4% 30.06 US$25,314
2015-12-15 2015-12-15 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
1,778 -61.8%
30.00
US$53,340 		1,778 -61.8% 30.00 US$53,340
2015-12-15 2015-12-11 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
8,222 -88.2%
30.33
US$249,373 		8,222 -88.2% 30.33 US$249,373
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
2,200 -66.7%
28.78
US$63,316 		2,200 -66.7% 28.78 US$63,316
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
10,000 -75.2%
28.78
US$287,800 		10,000 -75.2% 28.78 US$287,800
2015-10-27 2015-10-26 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
2,000 +inf%
18.45
US$36,896 		2,000 +inf% 18.45 US$36,896
2015-10-26 2015-10-26 B Purchase Kong Garheng Non-Executive Director
2,830 +inf%
17.43
US$49,335 		2,830 +inf% 17.43 US$49,335
2015-06-24 2015-06-22 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
50,000 -99.9%
35.74
US$1,787,000 		50,000 -99.9% 35.74 US$1,787,000
2015-05-27 2015-05-22 S Sale Fernandes Prabhavathi

President and CEO

Executive Director
9,000 -3.5%
35.72
US$321,489 		9,000 -3.5% 35.72 US$321,489
2014-05-28 2014-05-23 B Purchase JOHNSON JOHN Non-Executive Director
10,000 +inf%
9.10
US$90,980 		10,000 +inf% 9.10 US$90,980
2013-08-01 2013-06-19 B Purchase NEFF P SHERRILL Non-Executive Director
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2013-08-01 2013-06-19 B Purchase Quaker BioVentures II LP Large shareholder
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2014-05-13 2013-05-09 B Purchase Fernandes Prabhavathi

President and CEO

Executive Director
3,500 +1.7%
8.60
US$30,100 		3,500 +1.7% 8.60 US$30,100
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +3.5%
6.00
US$100,002 		16,667 +3.5% 6.00 US$100,002
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.6%
6.00
US$99,996 		16,666 +3.6% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.3%
6.00
US$99,996 		16,666 +3.3% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.1%
6.00
US$6,150 		1,025 +0.1% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +2.3%
6.00
US$100,002 		16,667 +2.3% 6.00 US$100,002
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
732,989 +119.7%
6.00
US$4,397,934 		732,989 +119.7% 6.00 US$4,397,934
2012-02-09 2012-02-08 B Purchase NEFF P SHERRILL Non-Executive Director Large shareholder
1,189,805 +57.4%
6.00
US$7,138,830 		1,189,805 +57.4% 6.00 US$7,138,830
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
488,659 +33.0%
6.00
US$2,931,954 		488,659 +33.0% 6.00 US$2,931,954
2012-02-09 2012-02-07 B Purchase Aisling Capital II LP Large shareholder
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
2012-02-09 2012-02-07 B Purchase GOLDSTEIN DOV A MD Non-Executive Director
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
Explore more

More insider trading research around Melinta Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America